Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016.

Fosså, Alexander

Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016. [electronic resource] - Acta oncologica (Stockholm, Sweden) Jan 2020 - 101-105 p. digital

Publication Type: Letter; Multicenter Study

1651-226X

10.1080/0284186X.2019.1652765 doi


Adult
Allografts
Antineoplastic Agents, Immunological--therapeutic use
Brentuximab Vedotin--therapeutic use
Female
Hodgkin Disease--mortality
Humans
Male
Middle Aged
Norway
Recurrence
Stem Cell Transplantation
Survival Analysis
Transplantation, Autologous
Treatment Outcome